Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
AMIA Annu Symp Proc ; 2023: 663-668, 2023.
Article in English | MEDLINE | ID: mdl-38222401

ABSTRACT

In traumatology physicians heavily rely on computed tomography (CT) 2D axial scans to identify and assess the patient's injuries after an accident. However, in some cases it can be difficult to rigorously evaluate the real extent of the damage considering only the bidimensional slices produced by the CT, and some life-threatening lesions can be missed. With the development of 3D holographic rendering and extended reality (XR) technology, CT images can be projected in a 3D format through head-mounted holographic displays, allowing multi-view from different angles and interactive slice intersections, thus increasing anatomical intelligibility. In this article, we explain how to import CT scans into holographic displays for 3D visualization and further compare the methodolgy with traditional bidimensional reading.


Subject(s)
Augmented Reality , Holography , Multiple Trauma , Humans , Holography/methods , Tomography, X-Ray Computed , Multiple Trauma/diagnostic imaging , Imaging, Three-Dimensional
2.
JMIR Med Inform ; 3(3): e31, 2015 Sep 21.
Article in English | MEDLINE | ID: mdl-26392229

ABSTRACT

BACKGROUND: Surveillance of health care-associated infections is an essential component of infection prevention programs, but conventional systems are labor intensive and performance dependent. OBJECTIVE: To develop an automatic surveillance and classification system for health care-associated bloodstream infection (HABSI), and to evaluate its performance by comparing it with a conventional infection control personnel (ICP)-based surveillance system. METHODS: We developed a Web-based system that was integrated into the medical information system of a 2200-bed teaching hospital in Taiwan. The system automatically detects and classifies HABSIs. RESULTS: In this study, the number of computer-detected HABSIs correlated closely with the number of HABSIs detected by ICP by department (n=20; r=.999 P<.001) and by time (n=14; r=.941; P<.001). Compared with reference standards, this system performed excellently with regard to sensitivity (98.16%), specificity (99.96%), positive predictive value (95.81%), and negative predictive value (99.98%). The system enabled decreasing the delay in confirmation of HABSI cases, on average, by 29 days. CONCLUSIONS: This system provides reliable and objective HABSI data for quality indicators, improving the delay caused by a conventional surveillance system.

3.
J Microbiol Immunol Infect ; 48(3): 316-21, 2015 Jun.
Article in English | MEDLINE | ID: mdl-24183990

ABSTRACT

BACKGROUND: Ventilator-associated pneumonia (VAP) is one of the most serious treatment-related infections resulting in high mortalities and costs. Our hospital has implemented bundle care in the intensive care units (ICUs) with special focus on VAP prevention. This is a retrospective study to evaluate its efficacy. METHODS: We implemented a six-item VAP care bundle modified from that of the Institute for Healthcare Improvement at five surgical ICUs (SICUs) in the National Taiwan University Hospital. A multidisciplinary teamwork was involved in this bundle care. This study analyses the SICU utilization, ventilator utilization, and VAP incidence between January 2006 and March 2013 to assess the impact of VAP bundle in a clinical setting. RESULTS: A total of 28,454 SICU patients were analyzed in this study and patients under the age of 18 were excluded (n = 1329); eventually, 27,125 patients were enrolled, with 12,913 patients from the pre-VAP bundle phase and 14,212 from the post-VAP bundle phase. Patients from the post-VAP phase tended to be older (p = 0.024) and with shorter SICU stay (p = 0.006), and disease severity scores (Therapeutic Intervention Scoring System, Glasgow Coma Scale, and Acute Physiology and Chronic Health Evaluation II score) were lower in the post-VAP bundle phase (p < 0.001), except the Injury Severity Score (p = 0.729). In response to VAP bundle interventions, no difference in SICU utilization (p = 0.982) between the pre-VAP and post-VAP bundle phases was noted, whereas the ventilator utilization was significantly decreased, from 1148.5 ventilator days to 956.1 ventilator days (p < 0.001) monthly; the VAP density had remarkably decreased from 3.3 to 1.4 cases per 1000 ventilator days (p < 0.001). CONCLUSION: Implementation of VAP bundle care decreases the incidence of VAP at SICU. Multidisciplinary teamwork, education, and a comprehensive checklist to improve health-care workers' compliance are the keys to success.


Subject(s)
Critical Care/methods , Infection Control/methods , Patient Care Bundles/methods , Pneumonia, Ventilator-Associated/prevention & control , Adolescent , Adult , Aged , Female , Health Services Research , Hospitals, University , Humans , Incidence , Male , Middle Aged , Retrospective Studies , Taiwan/epidemiology , Treatment Outcome , Young Adult
4.
J Thorac Cardiovasc Surg ; 140(5): 1125-32.e2, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20708754

ABSTRACT

OBJECTIVE: The application of extracorporeal membrane oxygenation in adults has been increasing, but infections occurring during extracorporeal membrane oxygenation use are rarely described. METHODS: We retrospectively analyzed the prospectively collected data on nosocomial infection surveillance of 334 patients aged 16 years or more undergoing their first extracorporeal membrane oxygenation for more than 48 hours at a university hospital from 1996 to 2007 for respiratory (20.4%) and cardiac (79.6%) support. RESULTS: During a total of 2559 extracorporeal membrane oxygenation days, 55 episodes of infections occurred in 45 patients (13.5%), including 38 bloodstream (14.85 per 1000 extracorporeal membrane oxygenation days), 6 surgical site, 4 respiratory tract, 3 urinary tract, and 4 other infections. Stenotrophomonas maltophilia (16.7%) and Candida species (14.6%) were the predominant blood isolates. In stepwise logistic regression analysis, longer duration of extracorporeal membrane oxygenation use (odds ratio 1.003; 95% confidence interval, 1.001-1.005; P = .004), mechanical complications (odds ratio, 4.849; 95% confidence interval, 1.569-14.991; P = .006), autoimmune disease (odds ratio, 6.997; 95% confidence interval, 1.541-31.766; P = .012), and venovenous mode (odds ratio, 4.473; 95% confidence interval, 1.001-19.977; P = .050) were independently associated with a higher risk for infections during extracorporeal membrane oxygenation use. Overall in-hospital mortality was 68.3%, and its independent risk factors included older age (odds ratio, 1.037; 95% confidence interval, 1.021-1.054; P < .001), neurologic complications (odds ratio, 51.153; 95% confidence interval, 6.773-386.329; P < .001), and vascular complications (odds ratio, 1.922; 95% confidence interval, 1.112-3.320; P < .001), but not infections during extracorporeal membrane oxygenation use. CONCLUSIONS: Bloodstream infection was the most common infection during extracorporeal membrane oxygenation use. Duration of extracorporeal membrane oxygenation, mechanical complications, autoimmune disease, and venovenous mode seemed to be independently associated with infections.


Subject(s)
Bacterial Infections/etiology , Cross Infection/etiology , Extracorporeal Membrane Oxygenation/adverse effects , Mycoses/etiology , Adolescent , Adult , Aged , Antibiotic Prophylaxis , Bacterial Infections/microbiology , Bacterial Infections/mortality , Bacterial Infections/prevention & control , Cross Infection/microbiology , Cross Infection/mortality , Cross Infection/prevention & control , Extracorporeal Membrane Oxygenation/mortality , Female , Hospital Mortality , Hospitals, University , Humans , Logistic Models , Male , Middle Aged , Mycoses/microbiology , Mycoses/mortality , Mycoses/prevention & control , Odds Ratio , Retrospective Studies , Risk Assessment , Risk Factors , Taiwan , Time Factors , Young Adult
5.
Emerg Infect Dis ; 8(1): 63-8, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11749750

ABSTRACT

To determine the distribution and antimicrobial drug resistance in bacterial pathogens causing nosocomial infections, surveillance data on nosocomial infections documented from 1981 to 1999 at National Taiwan University Hospital were analyzed. During this period, 35,580 bacterial pathogens causing nosocomial infections were identified. Candida species increased considerably, ranking first by 1999 in the incidence of pathogens causing all nosocomial infections, followed by Staphylococcus aureus and Pseudomonas aeruginosa. Candida species also increased in importance as bloodstream infection isolates, from 1.0% in 1981-1986 to 16.2% in 1999. The most frequent isolates from urinary tract infections were Candida species (23.6%), followed by Escherichia coli (18.6%) and P. aeruginosa (11.0%). P. aeruginosa remained the most frequent isolates for respiratory tract and surgical site infections in the past 13 years. A remarkable increase in incidence was found in methicillin-resistant S. aureus (from 4.3% in 1981-1986 to 58.9% in 1993-1998), cefotaxime-resistant E. coli (from 0% in 1981-1986 to 6.1% in 1993-1998), and cefotaxime-resistant Klebsiella pneumoniae (from 4.0% in 1981-1986 to 25.8% in 1993-1998). Etiologic shifts in nosocomial infections and an upsurge of antimicrobial resistance among these pathogens, particularly those isolated from intensive care units, are impressive and alarming.


Subject(s)
Anti-Infective Agents/pharmacology , Candida/drug effects , Cross Infection/microbiology , Pseudomonas aeruginosa/drug effects , Staphylococcus aureus/drug effects , Anti-Bacterial Agents , Candidiasis/drug therapy , Candidiasis/epidemiology , Candidiasis/microbiology , Cefotaxime/pharmacology , Cross Infection/drug therapy , Cross Infection/epidemiology , Drug Resistance, Bacterial , Drug Resistance, Fungal , Escherichia coli Infections/drug therapy , Escherichia coli Infections/epidemiology , Escherichia coli Infections/microbiology , Humans , Methicillin Resistance , Microbial Sensitivity Tests , Pseudomonas Infections/drug therapy , Pseudomonas Infections/epidemiology , Pseudomonas Infections/microbiology , Taiwan/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...